Registry and Natural History of Epilepsy-Dyskinesia Syndromes
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Dyskinesia
Related studies linked through entity extraction aliases.
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Safety Study of ADS-5102 in PD Patients With LID
- Status
- COMPLETED
- Phase
- PHASE3
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
- Status
- COMPLETED
- Phase
- PHASE3
Famotidine for Levodopa-induced Dyskinesia in PD
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
- Status
- COMPLETED
- Phase
- N/A
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia
- Status
- COMPLETED
- Phase
- PHASE2
Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia
- Status
- COMPLETED
- Phase
- PHASE4
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
- Status
- COMPLETED
- Phase
- PHASE3
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
- Status
- COMPLETED
- Phase
- PHASE3